Found 8 matching trials
Withdrawal of Dupilumab in Severe Asthma PHASE4 Asthma management has been revolutionised by the development of biological ...
Show More Learn More & Join Trial
Complete Remission After Treatment With Biologics for Nasal Polyps PHASE4 In this RCT the investigators randomize patients who are treated with biolo...
Show More Learn More & Join Trial
Dupilumab De-escalation in Pediatric Atopic Dermatitis PHASE4 This is a pilot investigator-blinded, randomized clinical trial to assess t...
Show More Location
Johns Hopkins Univerisity
Learn More & Join Trial
Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid N/A This study was designed to be a retrospective, multicentre, observational s...
Show More Location
Peking University First Hospital
Learn More & Join Trial
Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors NA This project adopts a prospective, multicenter, randomized controlled clini...
Show More Location
YueYang Hosptial of Intergrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
Learn More & Join Trial
Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma PHASE2 Primary Objective:
To investigate the effects of Dupilumab (SAR231893/REGN...
Show More Location
Investigational Site Number 840047
Learn More & Join Trial
A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab PHASE3 The study will assess the safety and efficacy of lebrikizumab in adult and ...
Show More Location
River Region Dermatology and Laser
Learn More & Join Trial
Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up) PHASE3 Primary Objective:
To describe the long-term safety of dupilumab in treatm...
Show More Location
Investigational Site Number :840099
Learn More & Join Trial